$4.56
+2.8%LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.
Last Annual Value
6.91M
3-Year CAGR
37%
5-Year CAGR
%
10-Year CAGR
49%
| Company | Other Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
![]() LifeMD, Inc. NASDAQ:LFMD | 6.91M | N/A | N/A | N/A | |
![]() Alpha Teknova, Inc. NASDAQ:TKNO | 0.00 | N/A | N/A | N/A | |
![]() CVRx, Inc. NASDAQ:CVRX | 0.00 | N/A | N/A | N/A | |
![]() Kindly MD, Inc. NASDAQ:NAKA | 0.00 | N/A | N/A | N/A | |
![]() RxSight, Inc. NASDAQ:RXST | 0.00 | N/A | N/A | N/A | |
![]() Simulations Plus, Inc. NASDAQ:SLP | -4.24M | N/A | N/A | N/A | |
![]() Cerus Corporation NASDAQ:CERS | 0.00 | N/A | N/A | N/A | |
![]() Owens & Minor, Inc. NYSE:OMI | 94.33M | 20.7% | 19.1% | 33.2% | |
![]() 908 Devices Inc. NASDAQ:MASS | 69.91M | N/A | N/A | N/A | |
![]() Sight Sciences, Inc. NASDAQ:SGHT | 0.00 | N/A | N/A | N/A | |
![]() Sanara MedTech Inc. NASDAQ:SMTI | -10.47M | N/A | N/A | N/A |
Continue your LFMD research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.